Part 2: Implementing Clinical Trials: a Review of the Attributes of Exemplary Clinical Trial Sites
Overview
Affiliations
Part two of this series focuses on the remaining three exemplary attributes: quality assurance, multidisciplinary involvement in the clinical trial process, and clinical trials awareness programs.
Clemens S, Keiko Sekine A, Tovar-Moll F, Clemens R Vaccine X. 2022; 12:100238.
PMID: 36407818 PMC: 9647642. DOI: 10.1016/j.jvacx.2022.100238.
Clinical trials best practice checklist: Guidance for Australian clinical research sites from CT:IQ.
Williams J, Weekes L, Harvey S, Kumar A, Leigh M, Thiele F Contemp Clin Trials Commun. 2020; 20:100651.
PMID: 33024881 PMC: 7527699. DOI: 10.1016/j.conctc.2020.100651.
Dimond E, Zon R, Weiner B, St Germain D, Denicoff A, Dempsey K J Oncol Pract. 2015; 12(1):63-4, e23-35.
PMID: 26627979 PMC: 4976452. DOI: 10.1200/JOP.2015.005181.
Dimond E, St Germain D, Nacpil L, Zaren H, Swanson S, Minnick C Clin Trials. 2015; 12(3):246-56.
PMID: 25691600 PMC: 4420772. DOI: 10.1177/1740774515571141.
Denicoff A, McCaskill-Stevens W, Grubbs S, Bruinooge S, Comis R, Devine P J Oncol Pract. 2013; 9(6):267-76.
PMID: 24130252 PMC: 3825288. DOI: 10.1200/JOP.2013.001119.